Description x “Discover the natural way to manage epilepsy with Kent 55 Drops. Formulated with a blend of homeopathic ingredients, these drops are designed to support neurological health and reduce the frequency of seizures. Ideal for those seeking an alternative treatment, Kent 55 Drops are easy to use and integrate into your daily routine. Composition: Belladonna? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? D10 (EHPI) 16.66% v/v Cuprum metallicum? ? ? ? ? ? ? ? ? ?D12 (EHPI) 16.66% v/v Pulsatilla? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? D30 (EHPI) 16.66% v/v Silicea? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?D8 (EHPI) 16.7% v/v Zincum metallicum? ? ? ? ? ? ? ? ? ? ?D12 (EHPI) 16.7% v/v Indications: Epilepsy and seizures. Sudden loss of consciousness. Muscles stiffness and jerking. Dosage: In general use 10 drops three times daily in some water. Particles in medicine are part of it. (Shake well before use) Product. Enlistment. No: 0079830523” Read more
Kent 55 (epilepsy)
“Discover the natural way to manage epilepsy with Kent 55 Drops. Formulated with a blend of homeopathic ingredients, these drops are designed to support neurological health and reduce the frequency of seizures. Ideal for those seeking an alternative treatment, Kent 55 Drops are easy to use and integrate into your daily routine.
Composition:
Belladonna D10 (EHPI) 16.66% v/v
Cuprum metallicum D12 (EHPI) 16.66% v/v
Pulsatilla D30 (EHPI) 16.66% v/v
Silicea D8 (EHPI) 16.7% v/v
Zincum metallicum D12 (EHPI) 16.7% v/v
Indications:
Epilepsy and seizures.
Sudden loss of consciousness.
Muscles stiffness and jerking.
Dosage:
In general use 10 drops three times daily in some water. Particles in medicine are part of it. (Shake well before use)
Product. Enlistment. No:
0079830523”
₨200.00
Related products
-
Ginseng – LM
₨300.00 – ₨750.00Price range: ₨300.00 through ₨750.00 -
HR-102 (FISTU FISSRAID)
₨270.00 -
VACCININUM
₨300.00 – ₨700.00Price range: ₨300.00 through ₨700.00 -
Kali Arsenicosum
₨300.00 – ₨750.00Price range: ₨300.00 through ₨750.00





Reviews
There are no reviews yet.